Literature DB >> 126214

Alteration of membrane integrity by delta1-tetrahydrocannabinol.

B Laurent, P E Roy.   

Abstract

Delta1-tetrahydrocannabinol was found to be a potent inhibitor of some membrane-bound enzymes, such as Mg-ATPase, Na-K-ATPase and acetylcholinesterase. At a given concentration, the degree of inhibition varied for each enzyme; the inhibition was more pronounced for the enzymes that are parts of the membranes. As the kinetic parameters of these enzymes are functions of the membrane composition and organization, these parameters were studied in vitro in the presence of THC. Although the Mg-ATPase was inhibited by THC, there was no change in the allosteric behaviour of the enzyme, indicating that the alterations caused by THC did not affect the enzymatic structure. The Na-K-ATPase and acetylcholinesterase had a different allosteric behaviour as compared to controls; these modifications were like the alterations caused by the decrease in membrane fluidity. These results suggest the fact that THC is incorporated in the membranes and causes alterations in the physical organization of the membranes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126214

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  3 in total

1.  Decrease of serum alpha-tocopherol levels in rabbits after acute treatment with delta9-tetrahydrocannabinol.

Authors:  M Chiarotti; G V Giusti
Journal:  Experientia       Date:  1979-01-15

2.  Regarding the Mechanisms of Promiscuous Cannabinoid Pharmacology: An Elephant Has Entered the Room.

Authors:  Peter S Cogan
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-11

3.  Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development.

Authors:  Johannes Beiersdorf; Zsofia Hevesi; Daniela Calvigioni; Jakob Pyszkowski; Roman Romanov; Edit Szodorai; Gert Lubec; Sally Shirran; Catherine H Botting; Siegfried Kasper; Geoffrey W Guy; Roy Gray; Vincenzo Di Marzo; Tibor Harkany; Erik Keimpema
Journal:  JCI Insight       Date:  2020-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.